Log in
Lost password
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Xetra  >  Merck KGaA    MRK   DE0006599905

News SummaryMost relevantAll newsSector news 

Merck KGaA May Withdraw Research from Portugal over Debt-Report

07/09/2012 | 02:28am US/Eastern

German chemical company Merck KGaA (>> Merck KGaA) may withdraw future investments for research projects in Portugal worth tens of millions of euros unless the government hospitals stick to the agreed-upon debt repayments, German daily newspaper Financial Times Deutschland reports Monday.

Merck Portugal's manager Fritz Sacher told the paper the company's research projects are long-term and require mutual trust as a basis. "The Portuguese government's lacking payment habits undermine this trust," he is quoted as saying.

Portuguese government hospitals owe the pharmaceutical industry a total of more than 1.5 billion euros ($1.84 billion) and companies have to wait nearly 550 days on average until invoices are paid, FTD reports.

Some companies, including Roche Holding AG (ROG.VX), have already halted the sale of medications on credit to highly indebted countries like Portugal, Greece, Spain and Italy until outstanding debts are paid, the paper notes, but for many companies such drastic steps are difficult as they carry responsibility for people's wellbeing.

Withdrawing research projects is a way of putting pressure on the government, as Portugal is an attractive location for research investments, FTD says. "The conditions for certain research and human studies are as good as in the U.S., but it's significantly more cost-effective in Portugal," Sacher told the paper.

Newspaper website: http://www.ftd.de

Write to the Frankfurt Bureau at djnews.frankfurt@dowjones.com

Stocks mentioned in the article : Merck KGaA
React to this article
Latest news on MERCK KGAA
07:38a MERCK KGAA : Darmstadt, Germany, and Pfizer Announce Investigational Immunothera..
10/08 MERCK KGAA : EMD Serono Joins Industry Leaders for The Economist Events' War On ..
10/08 MERCK KGAA : Serono Announces Recipients of the Third Annual €1 Million Grant fo..
10/08 MERCK KGAA : Darmstadt, Germany, and Pfizer Announce FDA Orphan Drug Designation..
10/08 MERCK KGAA : EMD Serono Announces Recipients of the Third Annual €1 Million Gran..
10/07 MERCK KGAA : and Pfizer Announce Investigational Immunotherapy Avelumab Receives..
10/05 BIOMARIN PHARMACEUTICAL : Merck Agrees to Return Kuvan Rights to BioMarin Pharma..
10/03 MERCK KGAA : Serono Awards Grant for Growth Innovation at ESPE in Barcelona
10/03 MERCK KGAA : Serono Awards Grant for Growth Innovation at ESPE in Barcelona
10/01DJBioMarin to Acquire Global Rights to the Drug Kuvan
Duration : Period :
Merck KGaA Technical Analysis Chart | MRK | DE0006599905 | 4-Traders
Income Statement Evolution
More Financials